Donald Trump Pledges to End HIV/Aids Epidemic in America in States of Union Speech
Since his election, the president has dissolved the Office of National Aids Policy and dismissed the whole Presidential Advisory Council on HIV/Aids Donald Trump has made a pledge to end the HIV/Aids epidemic in America during the State of the Union speech. During his first two years in office, the…
This Powerful Short Film Highlights The Stigma That Still Surrounds HIV
#HIVDoesntDefineYou. A new short film titled JUS+ LIKE ME has been created to combat the stigma that still surrounds HIV. It profiles Philip Antony Dzwonkiewicz, an HIV activist and Mr Gay England 2018 on his journey to launch the campaign and break down myths that still persist. It was…
Why Are Millennials Most at Risk for HIV Transmission?
A host of social, cultural, and financial factors are keeping young people at high risk of contracting HIV. In the age of PrEP, it’s alarming that young gay and bisexual men ages 25 to 34 had the highest number of new HIV diagnosis in 2016, more than any other…
New Case of PrEP Failure Documented in San Francisco
Doctors have diagnosed a San Francisco man on PrEP with HIV. The case marks only the third documented occasion in the United States in which the widely-prescribed and lauded health regimen to prevent HIV infection has failed. The announcement came at IDWeek, a conference for members of the Infectious Diseases…
While England is Making PrEP Dramatically Cheaper, American Men Still Can’t Afford It
Thanks to a court ruling in the UK, a cheaper generic version of PrEP could be available in the future, but in the United States, only 4% of men who have sex with men are using the drug — and cost is a big culprit. PrEP has shown itself…
How Accessible is PReP in America, Anyway?
Health experts offer differing views on how easy (and affordable) it is to obtain the HIV-preventative drug. According to a July op-ed in The New York Times, “the major reason” why over 90% of the 1.2 million Americans who need Truvada (the brand drug used in the U.S. as PrEP),…
#BreakThePatent: How HIV activists are going after Gilead’s PrEP patent
Activists are pushing the government to “march in” and break the pharma giant’s Truvada patent. Their promise is tantalizing: end the HIV epidemic without a vaccine. But how? In an op-ed published this week in The New York Times, two prominent HIV activists and a physician argue “the solution comes in a…
Georgia Lawmaker Wants to Quarantine People with HIV
A Georgia Republican suggested quarantining people living with HIV during a House study committee meeting. State Rep. Betty Price, a Republican from Roswell, suggested quarantining people living with HIV during a House study committee meeting addressing the barriers HIV-positive people face. Price’s suggestion came Tuesday during a two-hour meeting of…
For The First Time, The CDC Admitted That HIV Can’t Be Transmitted If You’re Undetectable
Nearly half of all HIV-positive people in the U.S. have undetectable viral loads. The Centers for Disease Control has finally admitted what activists and medical experts have been saying for years: People whose HIV loads are undetectable can’t transmit the virus. It might seem like a given, but as HIV…
The FDA just approved generic Truvada, and the implications are immense
It’s a game-changing move that’s come as something of a shock to HIV advocates: the U.S. Food and Drug Administration (FDA) just approved a generic version of Gilead’s antiretroviral drug Truvada (tenofovir disoproxil fumarate/emtricitabine). What that means as far as what the drug will cost is still up in the…
Gay Men in Seattle Are Now Less Likely to Contract HIV Than Before
A new examination of data has shown that over generations gay men in Seattle are less likely to be infected by HIV now than previously, but racial disparities still exist. The data was presented at the International AIDS Society Conference in Vancouver, according to AIDS Map, and indicated that there has…